In this week’s DeviceTalks Weekly Podcast, Karen Long, managing director at KCK Group, says startups looking for funding have an opportunity to catch the eye and ear of investors. KCK, an active medtech investor, has been involved in two sizable investments this summer including Aerin Medical and NeuroPace. Both were portfolio companies, but Long says […]
NeuroPace
NeuroPace raises $67M for RNS system
NeuroPace announced today that it raised $67 million for its RNS system for treating refractory focal epilepsy. Accelmed Partners led the round, while an unnamed strategic investor, Revelation Partners, Soleus Capital and returning investors KCK Group and OrbiMed Advisors also participated, according to a news release. Mountain View, Calif-based NeuroPace’s financing includes $33 million in […]
NeuroPace wins FDA approval of MRI labeling for its neurostim system
NeuroPace announced today that FDA approval of MRI labeling for its RNS system for people living with seizures that do not respond to medication. The Mountain View, Calif.–based company touts its RNS system as the world’s only closed-loop brain-responsive neurostimulation system designed to prevent seizures at their source. It includes a neurostimulator, leads placed at […]
The 10 greatest medtech advances of the 2010s
From disposable endoscopes to TAVR to robotic surgery, there’s a whole host of medtech advances widely available now that weren’t around much 10 years ago. “In terms of technological advances, I would put this past decade as one of the most important for medical technology. From connected devices and robotics, to advances in material sciences […]
Ex-Medtronic CFO Ellis joins Inspire Medical board | Personnel Moves, August 2, 2019
Inspire Medical Systems last week named Gary Ellis, the former CFO at Medtronic (NYSE:MDT), to its board of directors effective immediately. Minneapolis-based Inspire Medical also said that Amzak Health managing partner Joyce Erony left the board effective yesterday. Ellis spent 27 years at Medtronic before retiring in 2016. “On behalf of the entire Inspire board […]
Huennekens out, Azarbarzin in at Verb Surgical | Personnel Moves, July 24, 2019
Veteran medtech executive Scott Huennekens is out as CEO of Verb Surgical, the robot-assisted surgery joint venture between Johnson & Johnson (NYSE:JNJ) and Google parent Alphabet (NSDQ:GOOGL), which today installed Kurt Azarbarzin in the corner office. Azarbarzin, himself a medical device industry longtimer, was co-founder & CEO of SurgiQuest until its 2016 acquisition by ConMed (NSDQ:CNMD), where he was named […]
NeuroPace epilepsy tech to be studied for binge eating
NeuroPace said today that its epilepsy neuromodulation technology will be studied for its efficacy in treating binge-eating disorder in certain patients. The Mountain View, Calif.-based company’s RNS system is a closed-loop technology approved to treat adults with medically refractory focal onset epilepsy. The clinical trial will examine whether neuromodulation could help patients with a body […]
7 medtech stories we missed this week: June 8, 2018
From Royal Philips receiving FDA clearance to NeuroPace launching its epilepsy treatment device, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. FDA clears Philips’s Ingenia Elition 3.0T MR scanner Royal Philips announced in a June 5 press release that it has received FDA 510(k) clearance for its Ingenia […]
These medtech companies raised the most VC last year
Perhaps there’s a ray of hope that venture capital funding is recovering a bit for the medical device industry. VC firms invested more than $2.8 billion in 2017, an increase of more than $647 million from 2016, according to the MoneyTree Report from PricewaterhouseCoopers (PwC) and CB Insights. There were a total 229 deals involving […]
NeuroPace touts 8-year brain-responsive neurostim trial data
NeuroPace today released eight-year prospective clinical study data from trials of its closed-loop brain-responsive neurostimulation system, touting a 73% median seizure reduction among patients. Data from the trials was presented at the American Epilepsy Society’s annual meeting in Washington D.C. this week, the Mountain View, Calif.-based company said. The data came from 256 adult patients across […]
NeuroPace raises $74m for anti-epilepsy implant
NeuroPace said today that it raised a $74 million funding round, saying it plans to use the infusion to speed the commercialization of its implantable neurostimulation device for treating epilepsy. Mountain View, Calif.-based NeuroPace said the round was led by the KCK Group and OrbiMed Advisors. NeuroPace’s RNS system monitors electrical activity in the brain, delivering stimulative therapy […]
